Synonyms:zolmitriptan, 139264-17-8, Zomig, Zomigoro, 311C90, Zomigon, Flezol, Zomig-ZMT, (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one, C16H21N3O2, BW-311C90, (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one, NSC-760383, Cvt-427, 2FS66TH3YW, CHEMBL1185, (4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one, DTXSID8045933, CHEBI:10124, (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone, (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone, (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one, Zomig Nasal Spray, Zomig ZMT, AscoTopand, AscoTop, Zolmitriptan [USAN], 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one, (4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone, (S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone, 2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-, (S)-, 311-C-90, DTXCID6025933, zipton, zolmitriptane, zolmitriptanum, zominat, Rapimelt, (4S)-4-((3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-5-YL)METHYL)-2-OXAZOLIDINONE, SMR000449310, CAS-139264-17-8, Zomig (TN), Zolmitriptan RapidFilm, UNII-2FS66TH3YW, 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone, Zolmitriptan [USAN:INN:BAN], (S)-4-[[3-[2-(Dimethylamino)ethyl]indol-5-yl]methyl]-2-oxazolidinone, NCGC00095155-01, MFCD00871503, Zolmitriptan (Zomig), KS-5072, Spectrum2_000728, ZOLMITRIPTAN [MI], ZOLMITRIPTAN [INN], ZOLMITRIPTAN [JAN], GTPL60, (4S)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one, ZOLMITRIPTAN [VANDF], SCHEMBL33336, ZOLMITRIPTAN [MART.], MLS000758208, MLS001424172, BIDD:GT0040, SPECTRUM1505281, ZOLMITRIPTAN [USP-RS], ZOLMITRIPTAN [WHO-DD], SPBio_000656, Zolmitriptan (JAN/USP/INN), Zolmitriptan, >=98% (HPLC), HMS1922B04, HMS2052K17, HMS2093O14, HMS2235I22, HMS3714H11, HMS3884A06, Pharmakon1600-01505281, ZOLMITRIPTAN [ORANGE BOOK], ZOLMITRIPTAN [EP MONOGRAPH], ACT04392, BCP10513, HY-B0229, Tox21_111455, ZOLMITRIPTAN [USP MONOGRAPH], BDBM50033383, CCG-38993, HB1801, NSC760383, s1649, AKOS015850706, Tox21_111455_1, DB00315, NC00382, NSC 760383, (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine, NCGC00263884-02, NCGC00263884-03, NCGC00263884-08, BZ164590, BW-311C90;311C90, SBI-0206762.P001, SW197762-2, Z0024, C07218, D00415, AB00698244-05, AB00698244_06, EN300-18567396, Q218820, SR-05000001693, J-007257, SR-05000001693-1, Zolmitriptan, United States Pharmacopeia (USP) Reference Standard, (4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone, (s)-4-{3-[2-(dimethylamino)ethyl]-1h-indol-5-ylmethyl}oxazolidin-2-one, (4S)-4-((3-(2-(Dimethylamino)ethyl) -1H-indol-5-yl)methyl)-2-oxazolidinone, (S) -N,N-Dimethyl-2- [5- (2-oxo-1,3-oxazolidin-4-ylmethyl) -1H -indol-3-yl]ethylamine, (S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one, (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H -indol-3-yl]ethylamine, 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-, 139264-25-8, ZMT
Pubchem:PUBCHEM:60857
Id:ab38d924-5587-52b9-ad6b-b102e56ea953
Description:nan
